DENTSPLY SIRONA (NASDAQ:XRAY) Given “Neutral” Rating at Piper Sandler

Piper Sandler restated their neutral rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research note issued to investors on Friday, Benzinga reports. The firm currently has a $32.00 price target on the medical instruments supplier’s stock, down from their prior price target of $35.00.

XRAY has been the topic of a number of other reports. Barrington Research restated an outperform rating and issued a $41.00 price target on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. Leerink Partnrs restated an outperform rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. StockNews.com upgraded shares of DENTSPLY SIRONA from a hold rating to a buy rating in a research note on Friday, January 19th. SVB Leerink began coverage on shares of DENTSPLY SIRONA in a report on Monday, February 26th. They set an outperform rating and a $42.00 price objective on the stock. Finally, Needham & Company LLC dropped their target price on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating on the stock in a research report on Friday. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of Moderate Buy and a consensus price target of $36.90.

DENTSPLY SIRONA Stock Down 0.3 %

DENTSPLY SIRONA stock opened at $28.29 on Friday. DENTSPLY SIRONA has a twelve month low of $26.27 and a twelve month high of $41.65. The firm has a market capitalization of $5.87 billion, a P/E ratio of -64.29, a P/E/G ratio of 1.15 and a beta of 1.00. The company has a current ratio of 1.43, a quick ratio of 0.95 and a debt-to-equity ratio of 0.54. The stock’s fifty day simple moving average is $32.13 and its 200-day simple moving average is $32.71.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million during the quarter, compared to the consensus estimate of $969.45 million. During the same quarter in the previous year, the firm earned $0.39 earnings per share. The firm’s quarterly revenue was down 2.6% on a year-over-year basis. As a group, equities analysts expect that DENTSPLY SIRONA will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were paid a $0.16 dividend. The ex-dividend date was Wednesday, March 27th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a yield of 2.26%. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors and hedge funds have recently added to or reduced their stakes in XRAY. Exchange Traded Concepts LLC increased its stake in shares of DENTSPLY SIRONA by 41.2% during the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock worth $51,000 after acquiring an additional 439 shares during the period. Asset Management One Co. Ltd. lifted its holdings in shares of DENTSPLY SIRONA by 5.0% in the 3rd quarter. Asset Management One Co. Ltd. now owns 89,835 shares of the medical instruments supplier’s stock valued at $3,069,000 after buying an additional 4,294 shares during the period. Xponance Inc. boosted its stake in shares of DENTSPLY SIRONA by 12.4% in the third quarter. Xponance Inc. now owns 37,292 shares of the medical instruments supplier’s stock valued at $1,274,000 after buying an additional 4,114 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in DENTSPLY SIRONA by 132.4% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 83,817 shares of the medical instruments supplier’s stock worth $2,863,000 after acquiring an additional 47,748 shares during the period. Finally, Strs Ohio raised its position in DENTSPLY SIRONA by 14.6% in the third quarter. Strs Ohio now owns 47,167 shares of the medical instruments supplier’s stock worth $1,611,000 after acquiring an additional 6,021 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.